<qa>  What is the name of the drug that is eligible for enrollment?- Patients who have received previous investigational agents or biologic therapy, such as tipifarnib, pirfenidone, Peg-intron, sorafenib, or other vascular endothelial growth factor VEGFR inhibitors are eligible for enrollment 